FDA Lands Califf As Top Deputy, Potential Next Commissioner
This article was originally published in The Tan Sheet
Executive Summary
Renowned cardiologist and clinical trial researcher Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco. Califf is director of Duke University’s Translational Medicine Institute and vice chancellor for Clinical and Translational Research.
You may also be interested in...
FDA Scales Back Near-Term Goals For Sentinel Postmarket Data Network
FDA’s Janet Woodcock said the agency has not been able to overcome budgetary restrictions that hamper previously discussed plans to develop the Sentinel postmarket drug safety surveillance system into a much broader national resource.
FDA Ready To Hire New Deputy Commissioner For Medical Products And Tobacco
The winning candidate would be the third to hold the position in two years; job notice will be corrected, though – top secret clearance is not required.
FDA’s Potential Black Hole: House Investigates Departure Of Acting Head Of Medical Products Office
Energy and Commerce Committee letter states public information discrepancies raised questions about Leona Brenner-Gati’s status and “the circumstances surrounding her resignation.”